100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Theme 5: Psychiatry II. A complete summary of all exam material! $5.51   Add to cart

Summary

Theme 5: Psychiatry II. A complete summary of all exam material!

 4 views  0 purchase
  • Course
  • Institution

Upon recommendation of my fellow students, I now sell my summaries! In this summary, I use a lot of images, tables and enumerations. This means you don't have to read long pieces of boring and complicated text. This summary contains all the material of the books, lectures and learning objectives. T...

[Show more]

Preview 4 out of 59  pages

  • January 23, 2023
  • 59
  • 2022/2023
  • Summary
avatar-seller
Theme 5:


Psychiatry II
Summary




1

,Inhoud
Week 17: MUS (medically unexplained symptoms), PPS (persistent physical symptoms) and somatic
symptom disorder..................................................................................................................................4
Introduction........................................................................................................................................7
Somatic symptom and related disorders............................................................................................9
Syndromes......................................................................................................................................9
Development, course and impact.................................................................................................11
Diagnosis.......................................................................................................................................11
Differential diagnosis....................................................................................................................12
Epidemiology................................................................................................................................12
Aetiopathogenesis........................................................................................................................12
Treatment.....................................................................................................................................13
Factitious disorders..........................................................................................................................15
Syndromes....................................................................................................................................15
Development, course and impact.................................................................................................15
Diagnosis.......................................................................................................................................15
Differential diagnosis....................................................................................................................15
Aetiopathogenesis........................................................................................................................16
Treatment.....................................................................................................................................16
Functional neurological disorder......................................................................................................17
History..........................................................................................................................................17
Definition of FND..........................................................................................................................17
Pathophysiology...........................................................................................................................18
Treatment.....................................................................................................................................18
Occupational medicine.....................................................................................................................20
The insurance physician and the assessment of occupational disability......................................20
The absenteeism and occupational disability in social context....................................................20
Week 18: Psychosis..............................................................................................................................22
Psychosis spectrum disorders...........................................................................................................22
Introduction..................................................................................................................................22
Syndromes....................................................................................................................................22
Development, course and impact.................................................................................................26
Diagnosis.......................................................................................................................................27
Differential diagnosis....................................................................................................................27
Epidemiology................................................................................................................................28
Aetiopathogenesis........................................................................................................................28

2

, Treatment.....................................................................................................................................29
Psychiatry and the law......................................................................................................................32
The medical treatment contracts act (WGBO)..............................................................................32
The psychiatric hospitals (Compulsory admission) act (Wet BOPZ)..............................................33
Medicines in psychiatry....................................................................................................................35
Antidepressants............................................................................................................................35
Antipsychotics...............................................................................................................................36
Benzodiazepines...........................................................................................................................37
New pharmaceuticals, like es-ketamine and psylocibin................................................................37
Week 19: Stagnation............................................................................................................................38
Personality disorders........................................................................................................................38
Introduction..................................................................................................................................38
Syndromes....................................................................................................................................38
Development, course and impact.................................................................................................44
Diagnosis.......................................................................................................................................44
Differential diagnosis....................................................................................................................45
Epidemiology................................................................................................................................45
Aetiopathogenesis........................................................................................................................46
Treatment.....................................................................................................................................47
Neurodevelopmental disorders........................................................................................................49
Introduction..................................................................................................................................49
Syndromes....................................................................................................................................49
Development, course and impact.................................................................................................54
Diagnosis.......................................................................................................................................55
Differential diagnosis....................................................................................................................55
Epidemiology................................................................................................................................56
Aetiopathogenesis........................................................................................................................56
Treatment.....................................................................................................................................57




3

, Week 17: MUS (medically unexplained symptoms), PPS
(persistent physical symptoms) and somatic symptom
disorder
MUS = physical symptoms that last for longer than a few weeks and which cannot be
satisfactorily explained after adequate medical examination.
40% of consultations about certain symptoms cannot be explained by a medical condition
MUS = not a specific disease  focuses on the symptoms that cause persistent functional
impairment
Steps in treatment:
1. The GP treats the patient
2. The GP works together with or sends the patient to other primary care providers 
physiotherapists or psychologists
3. Treatment provided by multidisciplinary teams or treatment centres




After 12-15 months: symptoms improved in 50-75% of patients  10-30% have an increase
in symptoms
A good doctor-patient relationship is important  improves prognosis
 Relationship is often pressured due to rising frustration
Non-specific symptoms:
 Fatigue
 Headache
 Dizziness
 Lack of concentration
 Memory problems
Assessment of MUS is based on 5 dimensions: SCEGS
1. Somatic  tells the patient that the symptoms and their burden are taken seriously
4

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller KatieZara. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $5.51. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

78998 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$5.51
  • (0)
  Add to cart